anthonyyazdaniml/gliner-biomed-balanced-curated-corpus huggingface dataset:
A patient care method through artificial intelligence-based monitoring related to one example of the present invention comprises: a first step in which a first collection unit obtains image information related to a user, a second collection unit obtains voice information related to the user, and a third collection unit obtains biometric information related to the user; a second step in which at least some of the plurality of information obtained by the first collection unit, the second collection unit, and the third collection unit is displayed through a display unit of a user table; a third step in which a server determines the health condition of the user based on at least some of the plurality of information obtained by the first collection unit, the second collection unit, and the third collection unit; and a fourth step in which the server controls the automatically generated first information based on the determined health condition to be displayed on the display unit of the user table, wherein the first information may be changed in real time based on the user&#39;s feedback regarding the first information and changes in the determined health condition and can be displayed on the display unit. According to the present invention, provided is an artificial intelligence emotional service which calms the mind of a patient by reflecting the image information (facial expressions, etc.), the voice information (rhyme, etc.), context (conversations through voice recognition, etc.) as well as vital signals (heart rate, oxygen saturation, etc.).
A virtual assistant/chatbot to improve clinical workflow for home renal replacement therapies is disclosed herein. A virtual assistant/chatbot includes a user interface configured to enable a patient to engage in a virtual chat session by typing, speaking, or otherwise providing information regarding a patient request or issue related to their renal replacement therapy. The virtual assistant/chatbot also includes a server configured to provide logic to respond to the patient&#39;s requests. The logic defines a sequence of questions and answers for resolving patient queries. The sequence of assistant/chatbot questions and patient answers may be configured in a node arrangement such that certain patient answers/requests lead to additional questions for additional information from a patient. The virtual assistant/chatbot is configured to answer patient requests automatically or determine when the patient request is to be immediately addressed by a clinician or later through a phone call, text, or email communication.
The present invention covers systems and methods for improving efficiency of treatment planning for orthopedic diseases. The invention provides various analytical tools. One such analytical tool allows design of personalized treatment plan using quantitative measurements of the relevant orthopedic structures as well as related information about the patient, where the quantitative measurements are obtained from 3D models of the orthopedic structures constructed using radiographic images of the structures. Another analytical tool allows the design of personalized implant models based on the patient&#39;s measurements. The personalized treatment plan and implant models can be evaluated by using another analytical tool based on biomechanical analyses. The evaluation results can be used by the system to modify and improve the treatment plan and implant models. A construction tool can be used to construct implant models by, for example, 3D printing. The system also has the capacity to generate reports for treatment planning.
The invention discloses a traditional Chinese medicine composition for treating intestinal obstruction. The traditional Chinese medicine names intestinal obstruction as &#39;obstruction and rejection&#39; and &#39;colon&#39;, the pathogeny mainly includes more enterocoel hydrops, vital function deficiency, qi stagnation and blood stasis, spleen qi deficiency and weakness and gastrointestinal malfunction, so that the intestinal obstruction syndrome is generated. Consequently, the traditional Chinese medicine composition selects the traditional Chinese medicines such as cortex magnoliae officinalis, Chinese carlesia root, semen dolichoris album, Cinnmonum camphora (linn.) presl, phaenosperma globosa munro ex benth., potentilla anserine, seed of Chinese wampee, faeces togopteri, aquilaria agallocha (lour.) roxb, semen persicae, radix polygoni multiflori, fructus aurantii and arillus longan which clear heat, discharge fire, activate blood, dissolve stasis, regulate vital energy, remove stasis and tonify spleen and qi to be decocted with water to form liquid, and the liquid is infused through a stomach tube. 112 examples of 120 patients of the clinical experiments are cured, the total efficiency reaches 93.3%, 20 doses of the traditional Chinese medicine compositions are taken for the most, abdominal symptoms are completely disappeared after taking 10-15 doses of the compositions generally, patients can normally eat, does not have the symptoms of abdominal distention, stomachache, nausea and vomiting after eating, and the traditional Chinese medicine composition is worth being clinically popularized and applied.
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a bioinformation measuring device and an exercise machine that surely authenticate measured bioinformation as a user&#39;s own bioinformation and motor function information.  &lt;P&gt;SOLUTION: In a sphygmomanometer 1, which is a bioinformation measuring device, first the user&#39;s finger print is taken by a fingerprint recognition part 105, and examined to see whether the user is a previously registered user or not. Then, in the fingerprint recognition part 105, the user&#39;s pulse wave is also measured. Furthermore, in a blood pressure measuring part 102 for measuring blood pressure, the user&#39;s pulse wave is also measured along with the user&#39;s blood pressure. In the sphygmomanometer 1, only when the pulse wave measured by the fingerprint recognition part 105 and the pulse wave measured by the blood pressure measuring part 102 are identical, information on the blood pressure measured by the blood pressure measuring part 102 is stored.  &lt;P&gt;COPYRIGHT: (C)2004,JPO
A vaporizable decongestant is supported and stabilized on a flexible foraminous carrier composed typically of open-cell plastic foam, cloth or other fibrous material such as nonwoven fabric. The term &#34;foraminous&#34; herein is intended to refer to a substance or medium containing minute openings or perforated by many minute apertures. The decongestant is placed on the surfaces within the interstices and minute apertures or on fibers from which the foraminous carrier is formed. Vaporization of the inhalable decongestant is facilitated by providing the potential for greatly increasing its exposed surface area. Distributing the decongestant composition over the large, expanded surface within the foraminous carrier is beneficial in enhancing both the volatilization and evaporation of the decongestant agent. It also prolongs the useful life of the product. Once vaporized, the aromatic decongestant is available for natural inhalation through the nose or mouth to help relieve one or more of the symptoms of cough, colds, nasal or chest congestion and related symptoms. The foraminous carrier is preferably provided in the form of a patch or sheet that is bonded to the skin to serve as a supporting base for the active decongestant agent. The patch defining the carrier is typically adhesively bonded to the upper part of the body, e.g. on the face, neck or chest, in a location where the decongestant is liberated into the air and can be inhaled through the mouth or nose.
The invention discloses stasis removing and pain relieving decotion for treating migraine. Migraine belongs to the scope of the traditional Chinese medicine &#39;headache&#39; and &#39;migraine wind&#39;, etc, and is a paroxysmal headache caused by vasomotor dysfunction. Thus, the invention selects the following tradition Chinese medicines: Corydalis, Millettia, Plum flower, Rugosa Rose, Green Tangerine Peel, Giant Typhonium, White Cardamom, Kadsura Pepper Stem, Blackberrylily Rhizome and Notopterygium, which can activate blood circulation, remove stasis, relieve pain and dispel wind and cold. The academy makes the medicines into decoction in preparation laboratory. By setting the control group and clinical trial, the total efficiency reaches 96.9%, the cure rate and the total efficiency is higher than that of the control group. In addition, the decotion has a low treatment cost and no side effect.
PURPOSE:To obtain a water dissolvable medical preparation of a fat-soluble substance excellent in the solubility, the heat resistance and the acid resistance by incorporating cyclodextrin and acacia and/or charasaponin. CONSTITUTION:After adding 0.1-2.0 times weight acacia and/or 0.01-0.5 times weight charasaponin to cyclodextrin and dissolving the mixture, &lt;=2 times weight fat-soluble substance (e.g. vitamin A or germ oil, etc.) is added for this total amount and the mixture is stirred and mixed. This mixture is diluted with water or polyalcohol, etc. to obtain a liquid water dissolvable medical preparation. Furthermore after drying it with the vacuum drying, a powdery or granular water dissolvable medical preparation of the fat-soluble substance is obtained when the crushing and the classification or the granulation is performed thereto. The storage stability is remarkably increased by adding 0.5-3wt% sodium ascorbate for the preparation prior to the addition of the fat-soluble substance.
The invention discloses a liver-protecting and lipid-lowering scented tea and a making method thereof. The liver-protecting and lipid-lowering scented tea comprises the following raw materials by weight: 15-25 parts of marigolds, 15-20 parts of Hangzhou white chrysanthemum, 10-15 parts of white plum blossoms, 8-12 parts of sorghum powder, 7-10 parts of chestnut kernel, 6-9 parts of longan, 5-7 parts of gynostemma pentaphyllum, 4-6 parts of ganoderma lucidum, 5-7 parts of phellodendron Chinese schneid, 4-6 parts of eucommia ulmoides oliver, 3-5 parts of semen sinapis, 5-7 parts of black Chinese wolfberry, 4-6 parts of Medoggreenpit-viper, 3-5 parts of liquorice, 5-7 parts of laver, 4-6 parts of pachyrhizus erosus starch, 5-7 parts of grape seed extract, 4-6 parts of tomato extract, 5-7 parts of cashew nuts, 3-5 parts of hawthorn, 5-8 parts of Pu&#39;er tea, 2-4 parts of rice nectar, and 5-10 parts of composite powder. The health care scented tea of the invention is fragrant and tasty, and exquisite and silky. Through scientific compatibility, the scented tea is nutritionally balanced. Through collocation of a variety of medicinal and edible traditional Chinese herbal medicines, the scented tea has good effects of beautifying and skin nourishing, kidney nourishing and eyesight improving, and the like, and can reduce the content of blood lipid and balance blood lipid. Moreover, the scented tea can effectively prevent and treat the symptoms of patients with cardiovascular disease, obesity, hyperlipidemia, or the like.
FIELD: biotechnology, veterinary virology. SUBSTANCE: method involves the use of the novel strain of equine infectious anemia virus N &#34;3-K-VNIITIBP-VIEV&#34; for antigen preparing. Strain is grown in horse embryo skin and/or muscle, or lung, and/or kidney cells up to accumulation of viruses at titer 10 5  ID 50/ml. Viruses are concentrated by ultrafiltration by 10-20-fold, lipid envelope is separated by treatment with ether in cold and the end product that is peptide (molecular mass is 24-26 kDa) carrying group-specific antigen determinants is obtained. After the concentration stage viral material can be subjected for purification by high-speed centrifugation and ultracentrifugation additionally. After separation of lipid envelope obtained antigen is purified by affinity chromatography additionally. In this case the end product is immunoelectrophoretically pure peptide. Obtained cultural antigen is used for kit making for identification of antigen of equine infectious anemia virus. Kits for identification of antibodies are designated for diagnosis of equine infectious anemia in RDP or IFA. Kit for identification of antigen is designated for titration of antigen of equine infectious anemia virus in the process of culturing. Kit for identification of antibodies in RDP has cultural antigen and specific precipitating serum. Kit for identification of antibodies in IFA has cultural antigen for immobilization on solid carrier, polystyrene plate and antispecies immunoglobulin class G (Ig G) conjugated with horse radish peroxidase. Kit for identification of antigen has cultural antigen for immobilization on solid carrier, polystyrene plate and Ig G to equine infectious anemia virus conjugated with horse radish peroxidase. Kits for IFA have gelatin, substrate for peroxidase reaction carrying out, detergent and buffer solutions also. Kits can contain positive and negative controls also. EFFECT: enhanced sensitivity, standard specification and specificity of cultural antigen and kits for identification of antibodies and antigen. 18 cl, 6 ex
NEW MATERIAL:A cis-diaminocyclohexanol platinum complex of formula I-VI (R&lt;1&gt;-R8 are H or OH excluding the case that two OH groups are bonded on one carbon atom constituting a cyclohexane ring). EXAMPLE:Dichloro[DL-2,3-diamino-(1,2/3)-cyclohexanol]platinum(II). USE:An antitumor agent soluble in water. It exhibits antitumor activity comparable to or higher than that of cisplatin and has lower toxicity than cisplatin. PREPARATION:An aqueous solution of a diaminocyclohexanol hydrochloride such as DL-2,3-diamino-(1,2/3)-cyclohexanol dihydrochloride is added to an aqueous solution of potassium chloroplatinate(II). The mixture is added with sodium bicarbonate and left stand in a refrigerator. The precipitated crystals are collected and washed to obtain the objective complex.
&lt;P&gt;PROBLEM TO BE SOLVED: To provide an apparatus for packing a solid powder cosmetic, which increases production efficiency, extremely saves labor and automatized.  &lt;P&gt;SOLUTION: A base 1 is equipped with a horizontal moving table 2. A cosmetic container supply part 3, a bulk packing part 4, a cosmetic container discharge part 6 and a press part are successively disposed on each of the fixed positions of the base. The horizontal moving table 2 is equipped with an outer mold 7, a middle mold 8 is liftably arranged in the outer mold 7. The cosmetic container supply part 3, the bulk packing part 4 and the cosmetic container discharge part 6 are furnished with actuators for lifting and lowering the middle mold 8, respectively. The bottom of the middle mold 8 is pressed by a piston projected from the top of the actuator and the middle mold is lifted and lowered. The press part is equipped with the actuator for lifting and lowering the cosmetic container supply part 3, the bulk packing part 4 and the middle mold 8 and a pressing part 14 which presses the bottom of the middle mold 8 by the piston projected from the top of the actuator and presses the surface of the bulk packed into the container.  &lt;P&gt;COPYRIGHT: (C)2004,JPO
A device may include a processor. The processor may be configured to receive data during a surgery. The processor may receive data representative of a patient&#39;s intraoperative air exchange. The data may represent air exchange for a patient&#39;s breath cycle. For example, data may include any of ventilator inlet flow rate, ventilator inlet pressure, ventilator output pressure, chest tube flow rate, or chest tube pressure. The processor may also receive data representative of a surgical parameter other than one related to air exchange. For example, this data may include any of patient medical record data, intraoperative reporting data, surgical procedure data, or the like. The processor may be configured to receive an updated machine learning model from a cloud resource. And the processor may output, during the surgery, information indicative of prolonged-air-leak-likelihood based on data.
PROBLEM TO BE SOLVED: To obtain a new compound useful for suppressing of atherosclerosis and coronary cardiac disease caused from increase of cholesterol, etc., by substituting with a heterocycle. SOLUTION: This phenylglycinolamide substituted with a heterocycle expressed by the formula I [A is quinolyl or expressed by the formula II (R&lt;3&gt; and R&lt;4&gt; are each H or phenyl, etc.; R&lt;5&gt; is phenyl or alkylthio, etc.); R&lt;1&gt; is a 3-8C alkyl, etc.; R&lt;2&gt; is expressed by the formula III (R&lt;13&gt; is expressed by the formula CH2 -OH; R&lt;14&gt; is hydroxyl, a halogen, etc.)] and its salt are selected as the objective compound. The compound of the formula I is produced by reacting a carboxylic acid of the formula IV with an amine of the formula H2 N-R&lt;2&gt; in an inert solvent in the presence of a base and/or an auxiliary. The inert solvent is e.g. ethers or a halogenated hydrocarbon, etc.  Preferably, the base is an alkali metal hydroxide and 1-5mol of the base is used to 1mol of the compound of the formula IV, and the reaction temperature is usually within a range of 0-150 deg.C, and the pressure is a normal pressure. A dehydrating agent is suitable as the auxiliary and the using amount is 0.5-3mol.
Monitoring patient compliance using a camera on a telecommunication device to record the individual pill opening of a blister pack. The automated system detects whether an individual pill seal within the blister pack has been broken using image recognition software. The system collates the data issued by individual telecommunication devices by updating a database and queries it against preset parameters set by an individual patient&#39;s relevant health care professional. The system issues reminders, delivers video instructions and information to patients through the application on the telecommunication device. This is triggered by the data uploaded from the telecommunication devices. The system issues reminders and information to health care professionals through the web based platform provided by the service. This is triggered by the data uploaded from the telecommunication devices. The database of patients held on the server can be downloaded by relevant healthcare practitioners using a web based platform.
PURPOSE:To obtain a photochemical medicine for cancers, comprising a pyrylium-based compound as an active ingredient. CONSTITUTION:This photochemical medicine contains a compound of the formula (ring X is a heterocyclic ring, X is O, S, Se or Te and ring X is a pyrylium ring or a pyrylium analog ring; R&lt;1&gt; and R&lt;2&gt; each is H, a halogen, sulfonate, amino, styryl, nitro, hydroxyl, etc.; R&lt;3&gt; is A or L-A; L is (CH=CH), a bifunctional group derived from an aryl, etc.; A is an aryl, etc.; Y&lt;-&gt; is an anion). The photochemical medicine is a medicine of a completely different type from an existing porphyrin-based medicine. The compound of the formula or its salt has excellent penetration to organism tissue and can effectively treat. Light rays having 600-1,000nm long wavelength can be used as treating irradiation light and have a high light absorption intensity. In the case of an injection, 0.1-10mg/ml of the compound of the formula is mixed with a solvent. In the case of an oral agent, 1-50wt.% of the compound of the formula is contained and pharmaceutically manufactured.
PURPOSE: To make efficient treatment of the high liquid pressure of the eyes by using and applying the clathrate complex of a prostaglandin compd. (salt) and cyclodextrin capable of lowering the intra-ocular pressure in and to prepn. of a compd. for the eyes. CONSTITUTION: The treatment of the high liquid pressure of the eyes is executed by using the clathrate complex of the prostaglandin compd. selected from a group consisting of &gt;=1 kinds of PGE2 , PGE2 d, their derivatives and pharmaceutically permissible salts capable of lowering the intra-ocular pressure and the cyclodextrin selected from a group consisting of one or more kinds of α-, β- and γ-cyclodextrins in the prepn. of the compd. for the eyes and applying the complex to the eyes in the amt. effective for the treatment. The compd. for the eyes is preferably an aq. soln. contg. 0.001 to 5% (W/V) cyclodextrin compd. (salt).
PROBLEM TO BE SOLVED: To obtain a peach resin with which removal of specific smell and decoloration are possible by dissolving the unrefined peach resin into water, adding an acid to make the resin acidic and bringing active carbon into contact therewith. SOLUTION: The unrefined peach resin which has the putrefaction smell and is colored dark brown is dissolved in the water; for example, 100g peach resin is dissolved in 1 liter water until the peach resin attains a concn. of preferably &lt;=50%. Next, acid (e.g.; citric acid, malic acid, hydrochloric acid, phosphoric acid), for example, a 10% citric acid sol, is added to the peach resin so as to attain pH of &lt;=6. Next, 10g active carbon (e.g.; powder active carbon or granular active carbon) is added to the peach resin and the mixture is stirred for 20 minutes at room temp. The mixture is subjected to reduced pressure filtration with a Buchner funnel precoated with 10g diatomaceous earth. The filtrate is recovered and the refined aq. soln. is neutralized. The neutralized soln. is subjected to concentrating, drying and pulverizing at need, by which the powdery peach resin is obtd.
PURPOSE:To obtain a hair tonic cosmetic excellent in effects, such as trichogenous, hair growth, alopecic preventive and antidandruff effects, by blending a specific amount or more of an extract from pine needles prepared after dipping raw pine needles in alcohols and preserving the dipped pine needles with other ingredients. CONSTITUTION:A hair tonic cosmetic, obtained after finely cutting raw pine needles, dipping and preserving the cut pine needles in glycols, e.g. ethylene glycol, polyhydric alcohols, e.g. glycerol, lower monohydradric alcohols, e.g. ethyl alcohol, water-miscible ketones, e.g. acetone, or water-miscible organic liquids, e.g. tetrahydrofuran, or solvents, such as a mixture of the above- mentioned liquids with water, then blending the resultant extract from the pine needles in an amount of &gt;0.3% expressed in terms of solid substance with other ingredients and capable of sustainedly promoting blood circulation of the scalp, activating hair matrix cells, exhibiting remarkable trichogenous (human hair growth promoting), hair growth, alopecic preventive effects, etc., simultaneously holding moderate moisture in the scalp and imparting also antidandruff effects.
PROBLEM TO BE SOLVED: To obtain the subject multiple unit type sustained release tablet that can reduce the deviation in elution rate caused by compression in the tabletting step and by the solubility of the active ingredient in water by admixing specific sustained release granule and powder part. SOLUTION: This pharmaceutical preparation contains the sustained release granules comprising the sustained release base coating core particles and the matrix of the active ingredient and the powdery part. As the sustained base, is preferably used ethyl cellulose, while the solvent for the base is preferably ethyl alcohol. The particle size of the active ingredient is adjusted to &lt;=20μm on the average in order to increase its deposition rate on the core particles. Further, in order to reduce change in the elution rate caused by compression molding, the sustained release is further coated with a protective layer of water- soluble polymer on its outer taper.  Thus, the matrix is formed with a mixture of the sustained release base and the active ingredient (drug), differing from the granules coated with sustained release agent on the surface, after the conventional drug layer is coated, and so the matrix layer is not broken and the hardness of the tablets can be increased, when the powdery part is admixed and tabletted.